CollabRx, Inc.

35 articles about CollabRx, Inc.

• CollabRx, Inc. Announces Adrienne Craig-Kennard As Vice President Of Global Business Development And Strategic Alliances

  1/19/2016

• CollabRx, Inc. Release: Oncology Tech Firm Merges With National Chain Of Medical Labs To Form Diagnostics Powerhouse

  11/3/2015

• Shareholders Of Medytox Solutions (MMMS) And CollabRx, Inc. (CLRX) Approve Merger

  11/2/2015

• CollabRx, Inc., Medytox to Merge

  4/16/2015

• CollabRx, Inc.Announces Proposed Public Offering Of Common Stock

  2/26/2015

• CollabRx, Inc. Announces Pricing Of Public Offering Of Approximately $3,000,000 Of Common Stock

  2/26/2015

• CollabRx, Inc. Announces Pricing Of Public Offering Of Approximately $4,800,000 Of Common Stock And Warrants

  2/20/2015

• CollabRx, Inc. Regains Compliance On Bid Price

  2/18/2015

• CollabRx, Inc. And Medytox Solutions Sign Non-Binding Letter Of Intent For Possible Business Combinatio

  1/22/2015

• CollabRx, Inc. Receives NASDAQ Listing Determination; Intends To Request Hearing

  1/21/2015

• CollabRx, Inc. Announces Receipt Of NASDAQ Notice Of Bid Price Deficiency

  11/24/2014

• CollabRx, Inc. Reports Second Quarter Fiscal Year 2015 Financial Results

  11/14/2014

• Cartagenia Partners With CollabRx, Inc. To Provide Pathology Laboratories And Cancer Centers Access To Personalized Information On Therapeutic Options

  11/10/2014

• Taglich Brothers Initiates Coverage On CollabRx, Inc.

  3/4/2014

• CollabRx, Inc. Initial Research Report Released

  2/26/2014

• CollabRx, Inc. Launches New Web App For Cynvenio's ClearID Breast Cancer Patients

  1/15/2014

• CollabRx, Inc. Schedules Second Quarter Fiscal Year 2014 Financial Conference Call and Business Update

  11/5/2013

• CollabRx, Inc. to Present at LD MICRO Invitational on October 2nd

  9/26/2013

• CollabRx, Inc. Appoints George Lundberg, M.D. as Chief Medical Officer

  9/4/2013

• CollabRx, Inc. Launches Commercial Service for the Interpretation of Clinical Cancer Sequencing

  8/8/2013